May 9 (Reuters) - Royalty Pharma PLC ( RPRX ):
* ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN SANOFI'S
FREXALIMAB
* ROYALTY PHARMA ( RPRX ) : PROPOSED DEAL FOR APPROXIMATELY $525
MILLION IN
CASH
* ROYALTY PHARMA ( RPRX ) : EXPANDS CO'S DEVELOPMENT-STAGE PORTFOLIO
TO 15
THERAPIES WITH COMBINED POTENTIAL TO GENERATE GREATER THAN $1
BILLION IN ANNUAL ROYALTIES
Source text for Eikon:
Further company coverage: